However, it did show that coronary artery disease was most strongly associated with smoking and that the second strongest association was with IDL. It was of interest that among those who were free of coronary artery disease, the men who currently smoked had higher levels of IDL apo B and of IDL triglyceride than did the men who never smoked or had not smoked for at least 2 years. However, even among those who never had smoked or had not smoked for at least 2 years, coronary artery disease was associated with increased levels of both IDL apo B and IDL triglyceride. Hence, although current smoking influenced IDL levels, the association between coronary artery disease and elevated IDL levels did not appear to depend on smoking. Since the majority of triglyceride-rich lipoproteins are found in the IDL fraction, these findings may be important in understanding the role of the triglyceriderich lipoproteins in atherosclerosis. Circulation 75, No. 1, 124-130, 1987. THE PRESENT STUDIES were undertaken to determine whether coronary artery disease is associated with an increase in the plasma concentration of intermediate-density lipoprotein (IDL). Initially, IDL was defined ultracentrifugally as the Sf 12-20 fraction and very low-density lipoprotein (VLDL) as the Sf 20-400
THE PRESENT STUDIES were undertaken to determine whether coronary artery disease is associated with an increase in the plasma concentration of intermediate-density lipoprotein (IDL). Initially, IDL was defined ultracentrifugally as the Sf 12-20 fraction and very low-density lipoprotein (VLDL) as the erogenesis has been reviewed.7 Hence, it is possible that VLDL remnants may be linked to atherogenesis.
Patients with type III hyperlipoproteinemia have a marked increase in the incidence of coronary artery disease and in the remnants of triglyceride-rich lipoproteins. 8 In 1951, Jones et al.9 had already observed an increase in the concentration of the Sf 12-20 subfraction of lipoproteins in male survivors of myocardial infarction. More recently, Nestel et al. 0 have reported an increase in IDL levels in patients with chronic renal failure, a disorder associated with accelerated atherogenesis. That group has also reported that, at least in women, IDL levels are correlated with the severity of coronary artery disease. " Against this background, we reported a pilot study suggesting that coronary artery disease can be associated with increased levels of IDL.'2 The present study was undertaken to examine this more definitively and to determine whether it was independent of changes in other lipoproteins. During the study, we also observed that smoking can increase the level of IDL. Methods
Participants. This study was conducted on 45-to 65-yearold Caucasian male volunteers. Subjects were excluded for any of the following reasons: hypercholesterolemia (plasma level of cholesterol >90th percentile)'3; hyperapobetalipoproteinemia (normal cholesterol plus VLDL apo B > 120 mg/dl)'4; history of diabetes or fasting plasma glucose exceeding 125 mg/dl (7 mM/liter); gross obesity (body mass index >30 kg/m2) or body weight change within the preceding month; hypertension (systolic pressure > 140 mm Hg or diastolic pressure > 90 mm Hg); laboratory evidence of hepatic disease (aspartate amino transferase >60 U/liter, alkaline phosphatase >90 U/liter); renal disease (proteinuria creatinine > 1.2 mg/dl or > 1 10 mM/liter); hypothyroidism (thyroid-stimulating hormone > 10 mU/liter) or hyperuricemia (urate >7.6 mg/dl or >450 ,uM/liter); operation or major illness (e.g., myocardial infarction, etc.) within preceding 3 months; use of lipid-lowering drugs, thyroxine, insulin or oral hypoglycemics, fl-blockers, diuretics, steroids, or amiodarone; alcohol consumption within preceding 72 hr; or the consumption of a lipid-lowering diet. The participants were divided into two groups with respect to coronary artery disease: unaffected and affected. To reduce the probability that either group would be biased, we recruited each from three populations. Those 24 with the use of the BMDP Statistical Software package. The stepping computations were based on the maximum likelihood ratio and the method of backward elimination was used. With this approach, the components of an interaction are not eligible for removal until the interaction itself has been eliminated.
Results
Characteristics of participants. The selection criteria are outlined above. There were no differences with respect to age or body mass index between the two populations or among the subgroups ( with LDL apo B levels over 120 mg/dl were excluded. Hence, the plasma cholesterol and LDL cholesterol levels were normal and equal in each population and no study subject had hyperapobetalipoproteinemia.
The plasma triglyceride levels of the patients with coronary artery disease were greater than those of the subjects without disease (table 2) . Thus, hypertriglyceridemia was associated with coronary artery disease even in normocholesterolemic men. HDL cholesterol levels were marginally lower in those with coronary artery disease than in those without disease. Levels of VLDL triglyceride, but not of cholesterol, were higher in the population with coronary artery disease. The amount of VLDL was, however, so low that the VLDL apo B levels were at or below the limits of our assay and therefore are not given. We confirmed (table 2) our previous observation4 that the majority of the triglyceride-rich lipoproteins are in the IDL fraction`3 and that differences in plasma triglyceride levels are mainly due to an increase in the number (as reflected by apo B) rather than the size of these lipoprotein particles. Table 2 shows that the levels of IDL apo B and IDL triglyceride were significantly increased in subjects with coronary artery disease as compared with levels in those without disease.
Correlations. AChi-squared analysis with the Yates correction of numbers of individuals with and without coronary artery disease in the top vs bottom quintile for IDL triglyceride, IDL apo B, and the product of both.
-.006) and IDL triglyceride x apo B (p = .006). Multivariate analysis. The data were then examined by stepwise logistic regression analysis. The dependent variable was the presence or absence of coronary artery disease and the independent variables were smoking, plasma triglyceride, VLDL triglyceride, LDL triglyceride, HDL cholesterol, and the previously noted interaction (the product) of IDL triglyceride x IDL apo B. Because of wide variation in the number of cigarettes smoked by individual subjects we used the fourth root of the packs x years for this analysis. HDL was the first independent variable rejected. After four steps, only smoking and the product of IDL triglyceride x IDL apo B remained in the equation and each was independently related to coronary artery disease (table 6). The suggestion that IDL's association with coronary artery disease is independent of smoking is consistent with the data (table 4) that showed that increased IDL levels were associated with coronary artery disease even among nonsmokers and exsmokers.
Discussion
There has been recurring interest in the atherogenic potential of the triglyceride-rich lipoproteins. Some believe them to carry little independent atherogenic risk when considered together with cholesterol, LDL, or HDL.29 30 Others have argued for their independent effect.3"-36 In our study, like the Stockholm Prospective Study,31 32 an association between hypertriglyceridemia and coronary artery disease was observed in normocholesterolemic men. Carlson and Bottiger33 have argued that one possible reason for such an observation in the Stockholm Study, but not in others, might relate to the use of more definite end points in the Stockholm Study. Another study, in Uppsala, also identified hypertriglyceridemia as a risk factor for coronary artery disease when definite but not when 128 Sf 12-60 lipoproteins and the severity of coronary artery disease in Australian women but not, in contrast to our study, in men. There were design features that could account for this difference. Although Reardon et al. used the same definition of IDL that we have used, they looked at gradations of coronary artery disease rather than its presence or absence and they gave the lowest score to individuals with less than 50% stenosis. We considered only those with less than 25% stenosis or more than 70% stenosis and did not examine those who fell between both extremes. The present study was more rigorous in excluding those with associated risk factors or on lipid-altering medications. Furthermore, we attempted to look at more representative groups of those with and without disease and so did not restrict study subjects to those who "presented for coronary arteriography."
HDL cholesterol was somewhat reduced in those with coronary artery disease. The possible importance of HDL lies in the demonstrations of a "protective" effect of this lipoprotein in relation to coronary artery disease4'`and the frequent, but not 10, 12 and may contribute to the accelerated atherosclerosis observed in these patients. The present study not only points out the association of IDL with coronary artery disease, but also the potential pitfalls in regarding hypertriglyceridemia as one entity and in failing to examine defined lipoprotein subfractions when considering the atherogenic potential of the triglyceride-rich lipoproteins.
